Drugs / Lu AF76432
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03531229 | Apr 2018 → Feb 2019 | — | H. Lundbeck A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AF76432 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03531229 ↗ |
| Route | Oral | “Lu AF76432 oral solution 2.5 mg/ml” NCT03531229 ↗ |